Total serum tryptase: A predictive marker for KIT mutation in acute myeloid leukemia
Authors:
- Roberto CairoliRCRoberto Cairoli
- Carla Barbara RipamontiCRCarla Barbara Ripamonti
- Alessandro BeghiniABAlessandro Beghini
- Simonetta GranataSGSimonetta Granata
- Giovanni GrilloGGGiovanni Grillo
- Matteo BrioschiMBMatteo Brioschi
- Gianpaolo NadaliGNGianpaolo Nadali
- Assunta ViolaAVAssunta Viola
- Chiara CattaneoCCChiara Cattaneo
- Liliana InropidoLILiliana Inropido
- Erika RavelliERErika Ravelli
- Giambattista BertaniGBGiambattista Bertani
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 33 (9) , 1282-1284
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2006
- Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective studyBlood, 2006
- Myelomastocytic Leukemia: Evidence for the Origin of Mast Cells from the Leukemic Clone and Eradication by Allogeneic Stem Cell TransplantationClinical Cancer Research, 2005
- Quantitation of Minimal Residual Disease in Acute Myeloid Leukemia by Tryptase Monitoring Identifies a Group of Patients with a High Risk of RelapseClinical Cancer Research, 2005
- Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsivenessBlood, 2003
- Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemiaBlood, 2001
- Trisomy 4 Leading to Duplication of a Mutated KIT Allele in Acute Myeloid Leukemia with Mast Cell InvolvementCancer Genetics and Cytogenetics, 2000